Oramed Pharmaceuticals Inc. (ORMP)
NCM · Common · CUSIP 68403P203
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ORMP and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
68403P203
Market Cap
Small Cap · $406 Million
Business: Oramed Pharmaceuticals Inc. is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials.

Company Contact

CEO
Nadav Kidron, Esq
CFO
David Silberman
Headquarters
1185 Avenue of the Americas, Third Floor, New York, NY 10036
Phone
844-967-2633
Investor Relations
ir@oramed.com
General Email
estee@oramed.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »